Showing results (341-350 of 423) with videos related to

Sort By:
Pageof 43
Cells|March 14, 2020
Exosomes from Human Adipose Tissue-Derived Mesenchymal Stem Cells Promote Epidermal Barrier Repair by Inducing de Novo Synthesis of Ceramides in Atopic DermatitisKyong-Oh Shin, Dae Hyun Ha, Jin Ock Kim, et al.
The Journal of Investigative Dermatology|September 1, 2024
Sphingosine-1-Phosphate-Cathelicidin Axis Plays a Pivotal Role in the Development of Cutaneous Squamous Cell CarcinomaKyungho Park, Kyong-Oh Shin, Young-Il Kim, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Ablation of hematopoietic stem cell derived adipocytes reduces tumor burden in syngeneic mouse models of high-grade serous carcinomaElizabeth R Woodruff, Courtney A Bailey, Francis To, et al.
The Journal of Biological Chemistry|June 27, 2014
Mechanistic study of Uba5 enzyme and the Ufm1 conjugation pathwayJames M Gavin, Kara Hoar, Qing Xu, et al.
The Journal of Biological Chemistry|October 5, 2011
Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analoguesJesse J Chen, Christopher A Tsu, James M Gavin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 20, 2015
De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissueKathleen M Gavin, Jonathan A Gutman, Wendy M Kohrt, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 24, 2015
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension studyS Papapoulos, K Lippuner, C Roux, et al.
Cancer Cell|March 24, 2012
Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924Michael A Milhollen, Michael P Thomas, Usha Narayanan, et al.
Nature Immunology|June 9, 2016
Control of the innate immune response by the mevalonate pathwayMurali K Akula, Man Shi, Zhaozhao Jiang, et al.
Science Translational Medicine|September 15, 2021
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S Lightcap, Pengfei Yu, Stephen Grossman, et al.
Pageof 43